Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech Partners With Bio-Medical Science to Bring Sequencing Products to South Korea

NEW YORK – MGI Tech said on Thursday that it has signed a memorandum of understanding with South Korean life science tools distributor Bio-Medical Science (BMS) to bring its next-generation sequencing products to South Korea.

Under the agreement, the firms plan to collaborate to license, supply, manufacture, and distribute certain MGI Tech genetic sequencers and reagents in South Korea. BMS will provide these products, which will be "adapted to local needs" for genomic research and clinical diagnostics, according to the firms.

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality, and cost-effective solutions powered by our proprietary DNBSeq technology," Roy Tan, general manager of MGI Asia Pacific, said in a statement. "By joining forces with our partner BMS, MGI aims to facilitate more widespread adoption of genomics, multiomics, metagenomics, and related business locally in South Korea." 

Earlier this year, BMS and MGI partnered to establish a customer experience center in South Korea, "aiming to provide local customers with firsthand access to MGI's newer technologies and products," MGI said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.